Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Capital Leases (2016 - 2018)

Ironwood Pharmaceuticals' Capital Leases history spans 9 years, with the latest figure at $158000.0 for Q4 2018.

  • On a quarterly basis, Capital Leases changed N/A to $158000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $158000.0, a N/A change, with the full-year FY2018 number at $158000.0, changed N/A from a year prior.
  • Capital Leases hit $158000.0 in Q4 2018 for Ironwood Pharmaceuticals, up from $21000.0 in the prior quarter.
  • Over the last five years, Capital Leases for IRWD hit a ceiling of $3.2 million in Q2 2014 and a floor of $21000.0 in Q1 2017.
  • Historically, Capital Leases has averaged $1.3 million across 5 years, with a median of $687000.0 in 2015.
  • Biggest five-year swings in Capital Leases: skyrocketed 1494.95% in 2014 and later plummeted 91.7% in 2017.
  • Tracing IRWD's Capital Leases over 5 years: stood at $2.6 million in 2014, then plummeted by 88.1% to $306000.0 in 2015, then tumbled by 73.2% to $82000.0 in 2016, then crashed by 74.39% to $21000.0 in 2017, then surged by 652.38% to $158000.0 in 2018.
  • Business Quant data shows Capital Leases for IRWD at $158000.0 in Q4 2018, $21000.0 in Q1 2017, and $82000.0 in Q4 2016.